First new FDA-approved treatment option in nearly 20 years for families living with this rare lysosomal storage disease First FDA-approved medicine in emerging new class of biotherapeutics that ...
Morningstar: Neurolief receives FDA PMA Approval for First At-Home Brain Neuromodulation Therapy for Adults Whose Depression Was Not Adequately Improved by Antidepressants
Neurolief receives FDA PMA Approval for First At-Home Brain Neuromodulation Therapy for Adults Whose Depression Was Not Adequately Improved by Antidepressants
MedCity News: FDA Approval for Denali Therapeutics Blazes a New Trail for Brain-Penetrating Drugs
FDA Approval for Denali Therapeutics Blazes a New Trail for Brain-Penetrating Drugs
The Food and Drug Administration on Tuesday approved a generic medication for a rare brain disorder, while walking back suggestions by President Donald Trump and other administration officials that ...
Healthline: FDA Doesn’t Endorse Leucovorin for Autism, OKs It for Rare Brain Disorder
FDA Doesn’t Endorse Leucovorin for Autism, OKs It for Rare Brain Disorder